Company intelligence / Profile preview

IOP Ophthalmics

Costa Mesa, California, United States

Ownership: Private
Employees: ~163
Development stage: Other

Overview

IOP Ophthalmics was a U.S. ophthalmic medical technology company that developed, commercialized, and distributed specialty ophthalmic surgical devices and biologic products. The company focused on cornea/ocular surface, glaucoma, and oculoplastic subspecialty markets, with products sold to hospitals, surgery centers, and ophthalmic surgeons. Its portfolio included amniotic membrane technologies and other surgical implants and devices marketed under brands such as Ambio5, Ambio2, AmbioDisk, Molteno, and Tutoplast. IOP Ophthalmics was acquired by Katena in December 2013 and is no longer an independent active company.

Therapeutic areas: Ophthalmology
Modalities: DeviceBiologic
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on IOP Ophthalmics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IOP Ophthalmics.

Explore the full profile